NAD+ Subcutaneous Injections: What Medical Practices Need to Know
NAD+ sub-q injections at 500 mg and 1,000 mg are a popular add-on for med spas and longevity practices. Here is what you need to know about sourcing 503A compounded NAD+ compliantly.
NAD+ Subcutaneous Injections: What Medical Practices Need to Know
NAD+ (nicotinamide adenine dinucleotide) has become one of the most popular add-on offerings for medical spas, longevity practices, and integrative medicine clinics. As patient interest in cellular health and anti-aging protocols has grown, so has demand for compounded NAD+ in injectable form.
This post covers what medical practices need to know about sourcing and administering 503A compounded NAD+ subcutaneous injections.
What Is NAD+ and Why Are Patients Asking for It?
NAD+ is a coenzyme found in every cell of the body. It plays a central role in:
- Cellular energy production — NAD+ is essential for mitochondrial function and ATP synthesis
- DNA repair — NAD+ is a substrate for enzymes involved in DNA repair processes
- Sirtuin activation — sirtuins are proteins associated with longevity and metabolic regulation
- Circadian rhythm regulation — NAD+ levels fluctuate with the body's circadian cycle
NAD+ levels decline with age, and this decline has been associated with various aspects of metabolic aging. Supplementation via injection is thought to more reliably raise systemic NAD+ levels than oral supplementation, which faces significant first-pass metabolism.
Patients are asking for NAD+ because they have read about it in longevity research, heard about it from peers, or seen it offered at other practices. For medical spas and longevity clinics, it represents a meaningful revenue opportunity with strong patient retention characteristics.
Why Subcutaneous Injection — Not IV or Sublingual
At MedClinic Partners, we supply NAD+ in subcutaneous injection form only — at 500 mg/mL and 1,000 mg/mL concentrations.
This is a deliberate clinical and operational decision:
Sub-Q vs. IV Intravenous NAD+ administration requires a clinical setting with appropriate monitoring. IV infusions are time-intensive (often 2–4 hours) and require nursing oversight. Sub-Q injections can be self-administered by patients at home after proper instruction, which dramatically improves adherence and reduces the clinical burden on your practice.
Sub-Q vs. Sublingual Sublingual NAD+ has bioavailability questions that have not been fully resolved in the literature. Sub-Q injection provides more predictable systemic delivery.
Operational Simplicity Sub-Q injections fit naturally into the same workflow as GLP-1 injections. Practices already offering compounded semaglutide or tirzepatide can add NAD+ to their protocol with minimal operational changes.
Available Concentrations
We supply 503A compounded NAD+ subcutaneous injections in two concentrations:
500 mg/mL — Standard concentration for most protocols. Appropriate for patients starting NAD+ therapy or those on maintenance dosing.
1,000 mg/mL — Higher concentration for patients on more intensive protocols or those who prefer a smaller injection volume for the same dose.
Both concentrations are available as patient-specific 503A compounded preparations with up to 12-month BUD dates.
503A Compliance for NAD+ Orders
NAD+ subcutaneous injections are supplied as 503A compounded preparations. This means:
- Valid prescription required for each patient
- Patient-prescriber relationship must be established and documented
- State-licensed prescriber must authorize the order
- Documentation of clinical rationale is recommended
As with all compounded products, the prescribing provider is responsible for ensuring appropriate patient selection, dosing, and monitoring.
Integrating NAD+ Into Your Practice Protocol
NAD+ sub-q injections integrate well with several common practice models:
GLP-1 Weight Management Programs Many patients on semaglutide or tirzepatide protocols are interested in supporting cellular health alongside weight management. NAD+ is a natural add-on that increases average order value and patient engagement.
Longevity and Anti-Aging Programs For practices focused on longevity medicine, NAD+ is often a cornerstone offering alongside other cellular health interventions.
Executive Health Programs High-performing patients interested in cognitive function and energy optimization are a natural fit for NAD+ protocols.
Post-Procedure Recovery Some practices incorporate NAD+ into post-procedure recovery protocols for its potential role in cellular repair.
Pricing and Ordering
NAD+ subcutaneous injections are available through our 503A portal. Pricing varies by concentration and volume. Contact us for current pricing and availability.
For licensed medical providers only. NAD+ subcutaneous injections are 503A compounded preparations requiring a valid prescription. This content is for informational purposes and does not constitute medical advice.
Explore Topics
Written by
MedClinic Partners Editorial Team
B2B Medical Supply & Compounding Experts
The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.
